Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

AGM Trading Update

16 May 2024 07:00

RNS Number : 6135O
H&T Group PLC
16 May 2024
 

16 May 2024

 

H&T Group plc

("H&T", the "Company" or the "Group")

AGM Trading Update

H&T Group plc, the UK's largest pawnbroker and a leading retailer of high quality new and pre-owned jewellery and watches, is pleased to provide the following update for the four months trading period from 1 January 2024 to 30 April 2024 ("the period"), ahead of the Group's Annual General Meeting ("AGM") being held at 13:00 today.

The AGM will also be hosted digitally via a webinar. Shareholders can pre-register for live viewing of the meeting at https://handt.co.uk/pages/investor-relations.

Trading Update

Trading performance has been in line with expectations during the period.

Demand for pledge loans continues to be buoyant and April 2024 was a record month for lending. Consistent with last year, redemptions in March and April were higher than average as customers chose to collect their items, often to wear them at religious and family celebrations. This is expected to reverse in the coming months.

All key pledge book metrics remain in line with expectations. The Maxcroft pledge book has performed well since acquisition. The capital value of the Group's pledge book (excluding accrued interest and provisions) is currently £105m (31 December 2023: £101m, 30 April 2023: £91m).

Retail sales and foreign currency revenues are in line with forecasts, with retail margins improving as expected. Gold purchase and scrap revenues are benefitting from a strong gold price.

Three stores have been added to the store estate so far this calendar year, including Maxcroft, with one closure. The store estate currently stands at 280 stores.

Chris Gillespie, H&T Chief Executive, said:

"It is pleasing to be able to report a solid start to the year, with robust demand across the Group's product offering. I look forward to updating the market further as the year unfolds, and as always, I would like to pass on my grateful thanks to our amazing colleagues for their hard work, dedication, and unwavering commitment to customer service."

 

Enquiries

H&T Group plc

Chris Gillespie, Chief Executive Officer

Diane Giddy, Chief Financial Officer

 

+44(0)20 8225 2700

Shore Capital Ltd (Nominated Advisor and Broker)

Stephane Auton / Iain Sexton (Corporate Advisory)

Guy Wiehahn / Isobel Jones (Corporate Broking)

 

+44(0)20 7408 4090

Alma Strategic Communications (PR Advisor)

Sam Modlin

Rebecca Sanders-Hewett

Andy Bryant

Will Merison

 

+44(0)20 3405 0205

handt@almastrategic.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVANRSOUVAAR
Date   Source Headline
11th Aug 20207:00 amRNSUNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS
22nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSH&T appoints Chris Gillespie as executive director
29th Jun 20207:00 amRNSCOVID-19 update
23rd Jun 20201:36 pmRNSNotification of major holdings
11th Jun 20208:44 amRNSNotice of Annual Report Posting
18th May 20207:00 amRNSAGM Results
23rd Apr 20207:00 amRNSDirector Dealings and Issue of Equity
6th Apr 20207:00 amRNSCOVID-19 Update
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSAnnual Financial Report
27th Jan 20207:00 amRNSTrading Update and Notice of Results
14th Jan 20207:00 amRNSBoard changes
19th Nov 201912:39 pmRNSNotification of major holdings
18th Nov 20197:00 amRNSFCA review
8th Nov 20194:40 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
7th Nov 20194:40 pmRNSSecond Price Monitoring Extn
7th Nov 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20191:28 pmRNSAdditional Listing
30th Sep 20194:43 pmRNSAcquisition & Trading
18th Sep 20197:00 amRNSExecutive Director
5th Sep 20193:39 pmRNSAdditional Listing
13th Aug 20197:00 amRNSUnaudited Interim Condensed Financial Statements
7th Aug 20192:00 pmRNSNotice of Results
22nd Jul 20193:42 pmRNSFinancial Director
22nd Jul 201911:15 amRNSStephen Fenerty
12th Jul 20191:59 pmRNSNotification of Major Holdings
5th Jul 20195:39 pmRNSNotification of Major Holdings
2nd Jul 20197:00 amRNSResult of Placing
1st Jul 20194:35 pmRNSAcquisition and Placing
21st Jun 20197:00 amRNSNotice of Annual Report Posting
3rd May 20197:00 amRNSResult of AGM
23rd Apr 20197:00 amRNSAdditional Listing
4th Apr 20194:00 pmRNSDirector dealings and issue of equity
12th Mar 20197:00 amRNSPreliminary Results
23rd Jan 20197:00 amRNSTrading Update and Notice of Results
3rd Jan 20197:00 amRNSPerformance Share Plan Awards
21st Nov 20184:21 pmRNSNotification of Major Holdings
10th Oct 201812:00 pmRNSNotification of Major Holdings
11th Sep 20187:00 amRNSDirector/PDMR Shareholding
14th Aug 20187:00 amRNSInterim Results
27th Jul 20184:23 pmRNSIFRS 9 Transition Document
16th Jul 20184:18 pmRNSNotification of Major Holdings
20th Jun 201810:25 amRNSAdditional Listing
14th Jun 20185:32 pmRNSDirector Dealings
13th Jun 201812:19 pmRNSDirector Dealings
29th May 20184:14 pmRNSNotification of Major Holdings
29th May 20187:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.